Physician profile
Kevin Walsh
NPI 1245291657
$1,439.83
in general payments reported to CMS, 2019-2025
22 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $190 · 2021: $200 · 2022: $276 · 2023: $48.28 · 2024: $182 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $493.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $335.43 | 2019-2023 | Everest Spinal System |
| Depuy Synthes Sales INC. | $176.82 | 2019-2024 | Monovisc, Orthovisc, Peak |
| Pfizer INC. | $126.20 | 2019-2021 | |
| Abbvie INC. | $119.70 | 2025 | |
| Pacira Therapeutics, INC. | $109.65 | 2019-2021 | |
| Radius Health, INC. | $89.56 | 2020-2022 | |
| Bioventus LLC | $82.62 | 2020-2025 | Durolane |
| Zimmer Biomet Holdings, INC. | $50.91 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Fidia Pharma USA INC. | $48.74 | 2024-2025 | Hymovis, Triluron |
| Amgen INC. | $36.51 | 2021 | |
| Si-Bone, INC. | $33.93 | 2025 | |
| Dynasplint Systems INC. | $33.86 | 2019 | |
| Avanos Medical | $25.74 | 2023 | Trivisc Sodium Hyaluronate |
| Haemonetics Corporation | $25.05 | 2024 | Teg6s Hemostasis System |
| Orthogenrx INC. | $24.54 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $22.64 | 2025 | |
| Ferring Pharmaceuticals INC. | $22.08 | 2025 | Euflexxa |
| Almatica Pharma LLC | $18.36 | 2025 | Teriparatide |
| Djo, LLC | $17.53 | 2020 | |
| Paladin Technology Solutions | $15.12 | 2024 | |
| Arteriocyte Medical Systems, INC. | $12.88 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.